* OrthoPediatrics Corp KIDS.OQ reported a quarterly
adjusted
loss of 29 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -35 cents. The mean expectation of
seven analysts for the quarter was for a loss of 28 cents per
share. Wall Street expected results to range from -36 cents
to -24 cents per share.
* Revenue rose 21.4% to $37.61 million from a year ago;
analysts
expected $37.73 million.
* OrthoPediatrics Corp shares had fallen by 16.2% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for OrthoPediatrics
Corp is $38.50
This summary was machine generated from LSEG data March 6 at
10:37 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.28 -0.29 Missed
Sep. 30 2023 -0.23 -0.20 Beat
Jun. 30 2023 -0.22 -0.13 Beat
Mar. 31 2023 -0.36 -0.30 Beat